Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

McKesson Corp (NY: MCK )

456.70 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 456.70
Bid (Size) 395.47 (1)
Ask (Size) 466.88 (2)
Prev. Close 456.70
Today's Range 456.70 - 456.70
52wk Range 331.75 - 473.18
Shares Outstanding 154,674,571
Dividend Yield 0.54%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Teva Pharma is the way to play the re-rise of generic drugs
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth 
Via MarketBeat
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today
Via Benzinga

Performance

YTD
+22.00%
+22.00%
1 Month
+1.62%
+1.62%
3 Month
+8.33%
+8.33%
6 Month
+14.16%
+14.16%
1 Year
+19.62%
+19.62%

More News

Read More
(MCK) - Analyzing McKesson's Short Interest
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Biotech Stocks You’ll Regret Not Buying Soon: November 2023
Via InvestorPlace
Peering Into McKesson's Recent Short Interest
Via Benzinga
Analyst Ratings for McKesson
Via Benzinga
McKesson Unusual Options Activity For November 01
Via Benzinga
McKesson Corp. (NYSE: MCK) Sets New 52-Week High in Friday Session
Via Investor Brand Network
Topics Economy
Exposures Supply Chain
Qualcomm, Merck And 2 Other Stocks Insiders Are Selling
Via Benzinga
3 Evergreen Stocks for Long-term Wealth Generation
Via InvestorPlace
Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review
Via Investor's Business Daily
A Preview Of McKesson's Earnings
Via Benzinga
Here's How Much $1000 Invested In McKesson 20 Years Ago Would Be Worth Today
Via Benzinga
McKesson (MCK) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
McKesson Corporation Reports Fiscal 2024 Second Quarter Results and Raises Full Year Guidance
From McKesson Corporation
Via Business Wire
Top 3 Blue-Chip Stocks in the Healthcare Industry
Via InvestorPlace
Earnings Due For Stealth GLP-1 Weight-Loss Drug Play McKesson, Rivals
Via Investor's Business Daily
Fear & Greed Index Remains In 'Fear' Zone Ahead Of Fed's Decision
Via Benzinga
Topics Economy
Exposures Interest Rates
Peering Into McKesson's Recent Short Interest
Via Benzinga
Kraft Heinz, Yum China And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
McKesson Corporation Declares Quarterly Dividend
From McKesson Corporation
Via Business Wire
McKesson Aims For The $500 Milestone After Shattering Previous Record Highs And Outperforming The S&P 500!
Via Benzinga
Topics Stocks
Exposures US Equities
7 Healthcare Stocks That Can Cure a Lackluster Portfolio
Via InvestorPlace
Bankrupt Rite Aid, McKesson Strike Deal To Secure Steady Drug Deliveries
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.